A synthesized peptide derived from human Phospho-alpha Synuclein (S129)
Conjugation:
Unconjugated
Alternative Names:
Alpha-synuclein, NACP, non A-beta component of AD amyloid, PARK1, PARK4, PD1, SNCA,
SNCA a member of the synuclein family. Abundantly expressed in the brain. Inhibits phospholipase D2 selectively. May integrate presynaptic signaling and membrane trafficking. Implicated in the pathogenesis of Parkinsons disease. A major component of amyloid plaques in the brains of patients with Alzheimers disease. Two alternatively spliced isoforms transcripts have been identified.
